Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike RBD) |
RAS-T093 |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection. |
Human IgG antibody Laboratories manufactures the fusion peptide sequence and sars-cov reagents distributed by Genprice. The Fusion Peptide Sequence And Sars-Cov reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Peptide. Other Fusion products are available in stock. Specificity: Fusion Category: Peptide Group: Sequence And
SARS-CoV-2 IgG ELISA Kit |
Biovision |
100 assays |
EUR 903.6 |
SARS-CoV-2 - Mpro ELISA IgG |
ImmunoStep |
1 |
EUR 572 |
Description: SARS-CoV-2 - Mpro ELISA IgG |
SARS-CoV-2 - Spike ELISA IgG |
ImmunoStep |
1 |
EUR 572 |
Description: SARS-CoV-2 - Spike ELISA IgG |
SARS-CoV-2 - RBD ELISA IgG |
ImmunoStep |
1 |
EUR 572 |
Description: SARS-CoV-2 - RBD ELISA IgG |
Human IgG Anti SARS-CoV-2 Nucleoprotein Antibody (CR3009) |
The Native Antigen Company |
0.5 |
EUR 2361.56 |
Description: This is a recombinant monoclonal antibody for the detection of SARS-CoV-2 nucleoprotein. |
Human SARS-CoV-2 N IgG Antibody ELISA Kit |
Cusabio |
96Т |
EUR 595 |
|
Description: serum, plasma |
Sequence And information
SARS-CoV-2 (COVID-19) NSP8 Peptide |
9159P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) NSP8 Peptide |
SARS-CoV-2 (COVID-19) NSP9 Peptide |
9161P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) NSP9 Peptide |
SARS-CoV-2 (COVID-19) NSP9 Peptide |
9163P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) NSP9 Peptide |
SARS-CoV-2 (COVID-19) NSP8 Peptide |
9167P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) NSP8 Peptide |
SARS-CoV-2 (COVID-19) NSP2 Peptide |
9171P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) NSP2 Peptide |
SARS-CoV-2 (COVID-19) NSP2 Peptide |
9173P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) NSP2 Peptide |
SARS-CoV-2 (COVID-19) NSP4 Peptide |
9175P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) NSP4 Peptide |
SARS-CoV-2 (COVID-19) NSP6 Peptide |
9177P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) NSP6 Peptide |
SARS-CoV-2 (COVID-19) ORF6 Peptide |
9189P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) ORF6 Peptide |
SARS-CoV-2 (COVID-19) ORF8 Peptide |
9287P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) ORF8 Peptide |
SARS-CoV-2 (COVID-19) ORF8 Peptide |
9289P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) ORF8 Peptide |
SARS-CoV-2 (COVID-19) NSP10 Peptide |
9179P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) NSP10 Peptide |
SARS-CoV-2 (COVID-19) ORF9b Peptide |
9191P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) ORF9b Peptide |
SARS-CoV-2 (COVID-19) ORF3a Peptide |
9275P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) ORF3a Peptide |
SARS-CoV-2 (COVID-19) ORF3b Peptide |
9277P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) ORF3b Peptide |
SARS-CoV-2 (COVID-19) ORF3b Peptide |
9279P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) ORF3b Peptide |
SARS-CoV-2 (COVID-19) ORF3b Peptide |
9281P |
ProSci |
0.05 mg |
EUR 235.5 |
Description: SARS-CoV-2 (COVID-19) ORF3b Peptide |